Follow-up of patients with advanced NSCLC following 1st line chemotherapy. A British Thoracic Oncology Group national survey gan Darlison, L, Beckett, P, Calman, L, Mulatero, C, O'Byrne, K, Peake, M, Talbot, D

Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector, IMCgp100 in advanced uveal melanoma in two Phase 1 trials gan Carvajal, R, Sato, T, Shoushtari, A, Sacco, J, Nathan, P, Orloff, M, Corrie, P, Steven, N, Evans, J, Infante, J, Sznol, M, Mulatero, C, Hamid, O, Hernandez-Aya, L, Little, N, McAlpine, C, Krige, D, Hassan, N, Patel, S, Hulstine, A, Coughlin, C, Middleton, M